276 related articles for article (PubMed ID: 29074395)
21. Epigenetic modifications in cutaneous malignant melanoma: EZH2, H3K4me2, and H3K27me3 immunohistochemical expression is enhanced at the invasion front of the tumor.
Kampilafkos P; Melachrinou M; Kefalopoulou Z; Lakoumentas J; Sotiropoulou-Bonikou G
Am J Dermatopathol; 2015 Feb; 37(2):138-44. PubMed ID: 25614949
[TBL] [Abstract][Full Text] [Related]
22. Current Insights into Oral Cancer Epigenetics.
Irimie AI; Ciocan C; Gulei D; Mehterov N; Atanasov AG; Dudea D; Berindan-Neagoe I
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495520
[TBL] [Abstract][Full Text] [Related]
23. Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.
Herlihy N; Dogrusöz M; van Essen TH; Harbour JW; van der Velden PA; van Eggermond MC; Haasnoot GW; van den Elsen PJ; Jager MJ
Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1447-58. PubMed ID: 25593028
[TBL] [Abstract][Full Text] [Related]
24. [Epigenetics of schizophrenia: a review].
Rivollier F; Lotersztajn L; Chaumette B; Krebs MO; Kebir O
Encephale; 2014 Oct; 40(5):380-6. PubMed ID: 25127897
[TBL] [Abstract][Full Text] [Related]
25. Current insights into the epigenetic mechanisms of skin cancer.
Sang Y; Deng Y
Dermatol Ther; 2019 Jul; 32(4):e12964. PubMed ID: 31081988
[TBL] [Abstract][Full Text] [Related]
26. Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques.
Wierda RJ; Rietveld IM; van Eggermond MC; Belien JA; van Zwet EW; Lindeman JH; van den Elsen PJ
Life Sci; 2015 May; 129():3-9. PubMed ID: 25445221
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
Nowacka-Zawisza M; Wiśnik E
Oncol Rep; 2017 Nov; 38(5):2587-2596. PubMed ID: 29048620
[TBL] [Abstract][Full Text] [Related]
28. Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.
Lee JJ; Sholl LM; Lindeman NI; Granter SR; Laga AC; Shivdasani P; Chin G; Luke JJ; Ott PA; Hodi FS; Mihm MC; Lin JY; Werchniak AE; Haynes HA; Bailey N; Liu R; Murphy GF; Lian CG
Clin Epigenetics; 2015; 7(1):59. PubMed ID: 26221190
[TBL] [Abstract][Full Text] [Related]
29. Aberrant DNA methylation in malignant melanoma.
Schinke C; Mo Y; Yu Y; Amiri K; Sosman J; Greally J; Verma A
Melanoma Res; 2010 Aug; 20(4):253-65. PubMed ID: 20418788
[TBL] [Abstract][Full Text] [Related]
30. Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies.
Rubatto M; Borriello S; Sciamarrelli N; Pala V; Tonella L; Ribero S; Quaglino P
Melanoma Res; 2023 Dec; 33(6):462-474. PubMed ID: 37788101
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression.
Mannavola F; D'Oronzo S; Cives M; Stucci LS; Ranieri G; Silvestris F; Tucci M
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861757
[TBL] [Abstract][Full Text] [Related]
32. Roles of the EZH2 histone methyltransferase in cancer epigenetics.
Simon JA; Lange CA
Mutat Res; 2008 Dec; 647(1-2):21-9. PubMed ID: 18723033
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics of Epileptogenesis-Evoked Upregulation of Matrix Metalloproteinase-9 in Hippocampus.
Zybura-Broda K; Amborska R; Ambrozek-Latecka M; Wilemska J; Bogusz A; Bucko J; Konopka A; Grajkowska W; Roszkowski M; Marchel A; Rysz A; Koperski L; Wilczynski GM; Kaczmarek L; Rylski M
PLoS One; 2016; 11(8):e0159745. PubMed ID: 27505431
[TBL] [Abstract][Full Text] [Related]
34. The role of histone methyltransferase EZH2 in myelodysplastic syndromes.
Xu F; Li X
Expert Rev Hematol; 2012 Apr; 5(2):177-85. PubMed ID: 22475286
[TBL] [Abstract][Full Text] [Related]
35. Epigenetics and miRNAs in human cancer.
Fabbri M; Calin GA
Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
[TBL] [Abstract][Full Text] [Related]
36. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
37. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutations.
Barsotti AM; Ryskin M; Rollins RA
Epigenomics; 2015 Aug; 7(5):687-90. PubMed ID: 26317265
[No Abstract] [Full Text] [Related]
39. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic mechanisms and the relationship to childhood asthma.
Kabesch M; Michel S; Tost J
Eur Respir J; 2010 Oct; 36(4):950-61. PubMed ID: 20889464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
